1
|
Summer M, Ali S, Fiaz U, Tahir HM, Ijaz M, Mumtaz S, Mushtaq R, Khan R, Shahzad H, Fiaz H. Therapeutic and immunomodulatory role of probiotics in breast cancer: A mechanistic review. Arch Microbiol 2023; 205:296. [PMID: 37486419 DOI: 10.1007/s00203-023-03632-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Revised: 07/03/2023] [Accepted: 07/09/2023] [Indexed: 07/25/2023]
Abstract
Breast cancer has become the most prevalent and noxious type of malignancy around the globe (Giaquinto et al., 2022). Multiple clinical strategies including chemotherapy, radiotherapy, and immunotherapy have been in practice to manage breast cancer. Besides the protective roles of conventional remedial approaches, and non-reversible and deteriorative impacts like healthy cell damage, organ failure, etc., the world scientific community is in a continuous struggle to find some alternative biocompatible and comparatively safe solutions. Among novel breast cancer management/treatment options, the role of probiotics has become immensely important. The current review encompasses the prevalence statistics of breast cancer across the globe concerning developed and undeveloped counties, intestinal microbiota linkage with breast cancer, and association of breast microbiome with breast carcinoma. Furthermore, this review also narrates the role of probiotics against breast cancer and their mode of action. In Vivo and In Vitro studies under breast cancer research regarding probiotics are mechanistically explained. The current review systematically explains the immunomodulatory role of probiotics to prevent breast cancer. Last, but not the least, current review concludes the use of probiotics in the treatment of breast cancer through various mechanisms and future recommendations for molecular basis studies.
Collapse
Affiliation(s)
- Muhammad Summer
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Shaukat Ali
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan.
| | - Umaima Fiaz
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Hafiz Muhammad Tahir
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Muhammad Ijaz
- Department of Veterinary Medicine, University of Veterinary and Animal Sciences Lahore, Lahore, Pakistan
| | - Shumaila Mumtaz
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Rabia Mushtaq
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Rida Khan
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Hafsa Shahzad
- Department of Zoology, Government College University Lahore, Lahore, 54000, Pakistan
| | - Hashim Fiaz
- Department of Medicine and Surgery, Ammer-ul-din Medical College Lahore, Lahore, Pakistan
| |
Collapse
|
2
|
Block KI. Does Adjunctive Naturopathic Care Decrease Survival Rates in Breast Cancer Patients? Integr Cancer Ther 2021; 20:15347354211058399. [PMID: 34802294 PMCID: PMC8606965 DOI: 10.1177/15347354211058399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Keith I. Block
- Block Center for Integrative Cancer
Treatment, Skokie, IL, USA
| |
Collapse
|
3
|
Standish LJ, Sweet E, Kim E, Dowd F, McLaughlin R, Chiang P, Dale L, Gaul M, Andersen MR. Recurrence of Breast Cancer After Primary Treatment: A Matched Comparison Study of Disease-Free Survival in Women Who Do and Do Not Receive Adjunctive Naturopathic Oncology Care. Integr Cancer Ther 2021; 20:15347354211058404. [PMID: 34894812 PMCID: PMC8671681 DOI: 10.1177/15347354211058404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Revised: 08/05/2021] [Accepted: 10/21/2021] [Indexed: 12/04/2022] Open
Abstract
PURPOSE To compare disease free survival experienced by women who received usual oncologic care compared to a cohort of women who received naturopathic oncology care in addition to usual care. METHODS Women with breast cancer who received naturopathic oncology (NO) care in Western Washington State (WA) (N = 176) were recruited to a prospective study of clinical health-related quality of life outcomes and then matched to women who received usual care (UC) only (N = 334). RESULTS Among 510 women with breast cancer stages 1 to 3, a total of 50 women (10%) experienced a disease-free survival (DFS) ending event within the observation period; 23 (6.8% of those in the UC cohort, and 27 (15.3% of those in the NO cohort (P < .05). Although, women in the 2 cohorts received similar surgical, chemotherapy, and radiation treatment, women with breast cancer who received naturopathic oncology adjunctive care were less likely to use anti-estrogen therapy, and experienced poorer DFS (logrank test, P < .05). However, differences in DFS could not be shown to be due to cohort differences in anti-estrogen therapy, baseline HRQOL, or naturopathic oncology therapies prescribed. The stage 3 women in the naturopathic oncology group had more advanced disease at diagnosis. They were more likely to have 5 or more metastatic lymph nodes at baseline (18.5%) compared to their usual care matched control group (13%). Women in the naturopathic oncology group also had higher grade tumors at diagnosis. CONCLUSIONS Results show that recurrence of breast cancer was associated with more advanced malignant lymph node involvement; and that naturopathic oncology services provided in 2009-2015 did not improve disease-free survival in these high-risk breast cancer patients.
Collapse
Affiliation(s)
- L. J. Standish
- Bastyr University, Kenmore, WA,
USA
- University of Washington, Seattle, WA,
USA
| | - E. Sweet
- Bastyr University, Kenmore, WA,
USA
| | | | - F. Dowd
- Bastyr University, Kenmore, WA,
USA
| | | | | | - L. Dale
- Bastyr University, Kenmore, WA,
USA
| | - M. Gaul
- Fred Hutchinson Cancer Research Center,
Seattle, WA, USA
| | - M. R. Andersen
- University of Washington, Seattle, WA,
USA
- Fred Hutchinson Cancer Research Center,
Seattle, WA, USA
| |
Collapse
|
4
|
Yang W, Hao X, Qu J, Wang L, Zhang M, Jiang Y, Liu Y. Collaborative networks and thematic trends of research on the application of complementary and alternative medicine in cancer patients: A bibliometric analysis. Complement Ther Clin Pract 2019; 37:58-67. [PMID: 31487580 DOI: 10.1016/j.ctcp.2019.08.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Revised: 08/27/2019] [Accepted: 08/28/2019] [Indexed: 12/18/2022]
Abstract
BACKGROUND and purpose: Complementary and Alternative Medicine(CAM) has been greatly used in cancer patients. This research aimed to explore the research priorities of CAM for cancer patient's treatment. METHODS Web of Science(WoS), HistCite, BibExcel, GunnMap and VOSviewer were used to extract and visualize information. RESULTS 2768 articles published in 789 journals were indexed in the WoS from 1989 to 2018. The USA(n = 1009) and Technion-Israel Institute Technology(n = 58) were the most prolific country and institution, respectively. Keywords co-occurrence analysis indicated that the research hotspots around the world formed five clusters, so did the author co-citation analysis. The research priorities of the top-five countries, the top-three prolific authors and the co-citation core authors were also discussed, which reveals the differences and similarities among them. CONCLUSION This study delineates a framework for better understanding the situational use of CAM in cancer patients, which could help health care workers to prioritize and organize future research.
Collapse
Affiliation(s)
- Weimei Yang
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China
| | - Xinying Hao
- College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, PR China
| | - Jia Qu
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China
| | - Lan Wang
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China
| | - Meng Zhang
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China
| | - Yun Jiang
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China
| | - Yu Liu
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, PR China.
| |
Collapse
|
5
|
Finnell JS, Snider P, Myers SP, Zeff J. A Hierarchy of Healing: Origins of the Therapeutic Order and Implications for Research. Integr Med (Encinitas) 2019; 18:54-59. [PMID: 32549816 PMCID: PMC7217399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The philosophy, principles, and theories of naturopathic medicine include the six Principles of Naturopathic Medicine and the Therapeutic Order. Together these constructs, describe the core principles of the practice of naturopathic medicine, as established by thought leaders throughout the formation and development of the profession. The naturopathic medicine research agenda (NMRA) set forth recommendations for the codification of the foundational theories of naturopathic medical practice. The "Therapeutic Order, Whole-systems, Evidence-based Research Standards" (TOWERS) initiative is proposed with the primary objective to conduct the rigorous evaluation of the Principles of Naturopathic Medicine and the Therapeutic Order constructs. It is envisioned that this initiative will result in the development of an evidence-base concerning the clinical theory, philosophy and principles of whole-systems naturopathic medicine. After over one hundred years of professional organization and formal practice, there is a need to translate these empirically derived constructs into an evidence-informed theory of naturopathic medicine.
Collapse
Affiliation(s)
- John S Finnell
- Bastyr University Research Institute, Bastyr University, Kenmore, WA
| | - Pamela Snider
- Foundations of Naturopathic Medicine Institute, Snoqualmie, WA; National University of Natural Medicine, Portland, OR; Bastyr University, Kenmore, WA
| | - Stephen P. Myers
- National Centre for Naturopathic Medicine, Southern Cross University, Lismore NSW Australia; NatMed Research, Division of Research, Southern Cross University, Lismore NSW Australia; Foundations of Naturopathic Medicine Institute, Snoqualmie, WA
| | - Jared Zeff
- Naturopathic Medicine Institute, Vancouver, WA; National University of Natural Medicine; Foundations of Naturopathic Medicine Institute, Snoqualmie, WA
| |
Collapse
|
6
|
Andersen MR, Sweet E, Hager S, Gaul M, Dowd F, Standish LJ. Effects of Vitamin D Use on Health-Related Quality of Life of Breast Cancer Patients in Early Survivorship. Integr Cancer Ther 2019; 18:1534735418822056. [PMID: 30616390 PMCID: PMC7240878 DOI: 10.1177/1534735418822056] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Background: Vitamin D supplements may prevent recurrence, prolong
survival, and improve mood for women with breast cancer, although evidence for
these effects is preliminary. Methods: This report describes
vitamin D supplement use by 553 breast cancer patient/survivors (193 who used a
naturopathic oncology [NO] provider and 360 who did not) participating in a
matched cohort study of breast cancer outcomes. Results: We found
that more than half of breast cancer patients reported using vitamin D
supplements. Women who received care from NO providers in early survivorship may
be more likely to use vitamin D supplements (P < .05).
Approximately 30% of breast cancer patients with blood levels recorded in their
medical chart were potentially vitamin D deficient (<30 ng/mL). Vitamin D
supplement use at study enrollment was associated with higher levels of
self-reported health-related quality of life (HRQOL) at enrollment
(P < .05) and predicted better HRQOL at 6-month
follow-up (P < .05). Sufficient blood levels of vitamin D
recorded between enrollment and follow-up were also associated with better HRQOL
at follow-up (P < .05). Conclusions: Vitamin D
supplementation by breast cancer patients is common both during and after
treatment for breast cancer, but deficiency may also be common. NO and
conventional providers may be able to promote vitamin D sufficiency through
vitamin D supplementation and by encouraging healthy solar exposure. Further
studies should be undertaken examining whether vitamin D supplementation and
higher blood levels might improve HRQOL among women with breast cancer in early
survivorship.
Collapse
Affiliation(s)
- M Robyn Andersen
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,2 University of Washington, Seattle, WA, USA
| | | | - Shelly Hager
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Marcia Gaul
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Fred Dowd
- 3 Bastyr University, Kenmore, WA, USA
| | | |
Collapse
|
7
|
Andersen MR, Sweet E, Hager S, Gaul M, Dowd F, Standish LJ. Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis. Integr Cancer Ther 2018; 17:636-645. [PMID: 29607686 PMCID: PMC6142088 DOI: 10.1177/1534735418762543] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
Objective: This study sought to describe changes in the
health-related quality of life (HRQOL) of women who do and do not seek
naturopathic oncology (NO) complementary and alternative medicine (CAM) care
during and immediately after breast cancer treatment, and to explore the
predictive role of NO CAM care, demographic characteristics, and involvement in
decision-making on HRQOL in breast cancer survivors. Methods:
Matched cohorts of breast cancer survivors who did and did not choose to
supplement their breast cancer treatment with NO care within 2 years of
diagnosis participated. NO users were identified through naturopathic doctors’
clinics and usual care (UC) controls with similar prognosis were identified
through a cancer registry. The registry provided information about all
participants’ age, race, ethnicity, marital status, stage of cancer at time of
diagnosis, date of diagnosis, and use of conventional medical treatments
(surgery, chemotherapy, radiation, and endocrine therapy). Data of participants’
self-reported involvement in decision-making and HRQOL were collected at study
enrollment and at 6-month follow-up. Results: At 6-month follow-up,
the NO patients reported significantly more involvement in decision-making about
care and better general health than did UC patients (P <
.05). Self-reported involvement in decision-making about cancer treatment was
associated with better role-physical, role-emotional, and social-functional
well-being (P < .05). Race, age, marital status, and
congruence of preferred and achieved levels of involvement also predicted
aspects of HRQOL in breast cancer survivors (P < .05).
Conclusions: Both NO CAM care and involvement in
decision-making about cancer treatment may be associated with better HRQOL in
breast cancer survivors.
Collapse
Affiliation(s)
- M Robyn Andersen
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.,2 University of Washington, Seattle, WA, USA
| | | | - Shelly Hager
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Marcia Gaul
- 1 Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - Fred Dowd
- 3 Bastyr University, Kenmore, WA, USA
| | | |
Collapse
|